Michael Stark/LinkedIn
Jun 26, 2026, 01:48
Michael Stark: Highlights from ISBT 2026 on RBC Transfusion and NEC in Neonates
Michael Stark, Professor of Neonatal Medicine and Deputy Director of Clinical Research at the Robinson Research Institute, Director of Neonatal Medicine at the University of Adelaide and Head of Neonatal Services at the Women’s and Children’s Hospital Adelaide, shared a post on LinkedIn:
“For those us who thought the pinnacle of scientific poster design was reached by Australia’s own Prof Brett Manley at PAS 2026 for the PLUSS trial 2 year follow up take a look at this – not heaps of neonatal work at ISBT in Kuala Lumpur but the bar has been raised.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 16:26Gemma Postil: AI Tools in Modern Health Research
-
Sep 25, 2026, 16:01Mostafa Hammam: When aPTT Correction Is Not the End
-
Sep 25, 2026, 15:50Adam Boruchov: Registration Is Open For The 2026 New England Hematologic Diseases Symposium
-
Sep 25, 2026, 15:23Bringing Hope and Treatment Access to Morocco’s Hemophilia Community – World Federation of Hemophilia
-
Sep 25, 2026, 15:22Alejandro González Veliz: Targeting Atherosclerosis Before the First Event
-
Sep 25, 2026, 15:00Sarah Richardson: Finding Strength Through Bleeding Disorders Advocacy
-
Sep 25, 2026, 14:54James Fildes: Modeling Device Related Thrombosis in Multi Organ Systems
-
Sep 25, 2026, 14:51Platelet Metabolic Reprogramming: How Cellular Energy Drives Thrombosis
-
Sep 25, 2026, 14:46Thomas Maxwell: From Hemophilia Shame to Strength – Walking for Bleeding Disorders